OKKO Health hyperacuity, contrast and colour game validation in AMD
Research type
Research Study
Full title
OKKO Health hyperacuity, contrast and colour game validation in age-related macular degeneration
IRAS ID
319963
Contact name
Stephanie Campbell
Contact email
Sponsor organisation
Okulo Ltd
Clinicaltrials.gov Identifier
Duration of Study in the UK
0 years, 3 months, 1 days
Research summary
Smartphone apps have the potential to measure standard metrics of visual function. In addition, new tests may serve as digital biomarkers to detect early progression of disease, assess risk of developing disease or expand the patient’s clinical picture. Smartphones are inherently advantageous to reduce the reliance on specialist bulky and costly equipment that currently only exists in specialist clinics.
The OKKO Health app’s visual acuity game has evidence for a good association with visual acuity as measured on the gold-standard ETDRS chart in patients with age-related macular degeneration (unpublished data from Nottingham University Hospital).
This study aims to assess the clinical validity of three more games (i.e. contrast sensitivity, colour sensitivity and hyperacuity) against in-clinic gold standard measures and will be require participants to attend a private optometrist practice on one occasion only to conduct these tests.
REC name
London - Camden & Kings Cross Research Ethics Committee
REC reference
22/PR/1383
Date of REC Opinion
25 Oct 2022
REC opinion
Favourable Opinion